https://www.fedaiisf.it/en/alfasigma-opa-su-intercept-pharmaceuticals-da-793-milioni/
<trp-post-container data-trp-post-id='73487'>Alfasigma, opa su Intercept Pharmaceuticals da 794 milioni</trp-post-container>